FR2512672B1 - - Google Patents

Info

Publication number
FR2512672B1
FR2512672B1 FR8117492A FR8117492A FR2512672B1 FR 2512672 B1 FR2512672 B1 FR 2512672B1 FR 8117492 A FR8117492 A FR 8117492A FR 8117492 A FR8117492 A FR 8117492A FR 2512672 B1 FR2512672 B1 FR 2512672B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8117492A
Other languages
French (fr)
Other versions
FR2512672A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panmedica SA
Original Assignee
Panmedica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panmedica SA filed Critical Panmedica SA
Priority to FR8117492A priority Critical patent/FR2512672A1/fr
Priority to FR8213980A priority patent/FR2531713A2/fr
Priority to ES515709A priority patent/ES8306439A1/es
Priority to JP57160728A priority patent/JPS58109417A/ja
Priority to ZA826752A priority patent/ZA826752B/xx
Priority to CA000411517A priority patent/CA1219582A/en
Priority to GR69287A priority patent/GR77003B/el
Priority to US06/418,599 priority patent/US4472387A/en
Priority to DE8282401683T priority patent/DE3264433D1/de
Priority to DE198282401683T priority patent/DE74909T1/de
Priority to EP82401683A priority patent/EP0074909B1/fr
Priority to AT82401683T priority patent/ATE13975T1/de
Priority to AU88474/82A priority patent/AU557715B2/en
Publication of FR2512672A1 publication Critical patent/FR2512672A1/fr
Application granted granted Critical
Publication of FR2512672B1 publication Critical patent/FR2512672B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
FR8117492A 1981-09-16 1981-09-16 Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant Granted FR2512672A1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR8117492A FR2512672A1 (fr) 1981-09-16 1981-09-16 Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant
FR8213980A FR2531713A2 (fr) 1981-09-16 1982-08-11 Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant
JP57160728A JPS58109417A (ja) 1981-09-16 1982-09-14 セロトニンの代謝欠之を補正するための新規な薬剤
ES515709A ES8306439A1 (es) 1981-09-16 1982-09-14 "procedimiento de preparacion de un complejo inosina-(l) 5-htp".
CA000411517A CA1219582A (en) 1981-09-16 1982-09-15 Pharmaceutical compositions capable of increasing cerebral serotonin concentration
GR69287A GR77003B (enrdf_load_stackoverflow) 1981-09-16 1982-09-15
ZA826752A ZA826752B (en) 1981-09-16 1982-09-15 Pharmaceutical compositions capable of increasing cerebral serotonin concentration
US06/418,599 US4472387A (en) 1981-09-16 1982-09-16 Pharmaceutical compositions capable of increasing cerebral serotonin concentration
DE8282401683T DE3264433D1 (en) 1981-09-16 1982-09-16 Compositions on the basis of 5-hydroxy-tryptophane, manufacturing process and medicaments containing them
DE198282401683T DE74909T1 (de) 1981-09-16 1982-09-16 Zusammensetzungen mit gehalt an 5-hydroxytryptophan, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
EP82401683A EP0074909B1 (fr) 1981-09-16 1982-09-16 Nouvelles compositions à base de 5-hydroxytryptophane, leur procédé de préparation et médicaments les contenant
AT82401683T ATE13975T1 (de) 1981-09-16 1982-09-16 Zusammensetzungen mit gehalt an 5hydroxytryptophan, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
AU88474/82A AU557715B2 (en) 1981-09-16 1982-09-16 5-hydroxytryptophane and derivatives with nitrogenous heterocyclic compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8117492A FR2512672A1 (fr) 1981-09-16 1981-09-16 Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant

Publications (2)

Publication Number Publication Date
FR2512672A1 FR2512672A1 (fr) 1983-03-18
FR2512672B1 true FR2512672B1 (enrdf_load_stackoverflow) 1984-02-24

Family

ID=9262193

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8117492A Granted FR2512672A1 (fr) 1981-09-16 1981-09-16 Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant

Country Status (3)

Country Link
JP (1) JPS58109417A (enrdf_load_stackoverflow)
FR (1) FR2512672A1 (enrdf_load_stackoverflow)
ZA (1) ZA826752B (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0628311T3 (da) * 1992-07-08 2002-07-22 Kyowa Hakko Kogyo Kk Xanthinderivater som antidepressive midler

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1601066A (enrdf_load_stackoverflow) * 1966-06-18 1970-08-10
ES376906A1 (es) * 1970-02-25 1973-02-01 Made Labor Sa Un metodo de obtencion de alfa-cetoglutarato de piridoxina y 5-hidroxitriptofano.
GB1535778A (en) * 1976-12-06 1978-12-13 Mac Sweeney D Compounds useful in treatment of unipolar depression
DE2841170A1 (de) * 1978-09-21 1980-04-03 Pharmazeutische Praeparate Apo Hypnotikum

Also Published As

Publication number Publication date
FR2512672A1 (fr) 1983-03-18
JPS58109417A (ja) 1983-06-29
JPS6254403B2 (enrdf_load_stackoverflow) 1987-11-14
ZA826752B (en) 1983-07-27

Similar Documents

Publication Publication Date Title
FR2500249B1 (enrdf_load_stackoverflow)
DE3278448T2 (enrdf_load_stackoverflow)
FR2500960B1 (enrdf_load_stackoverflow)
FR2501197B1 (enrdf_load_stackoverflow)
FR2502101B1 (enrdf_load_stackoverflow)
FR2500553B1 (enrdf_load_stackoverflow)
FR2502004B3 (enrdf_load_stackoverflow)
FR2499297B1 (enrdf_load_stackoverflow)
FR2500833B1 (enrdf_load_stackoverflow)
CH669305GA3 (enrdf_load_stackoverflow)
FR2498838B3 (enrdf_load_stackoverflow)
FR2499642B1 (enrdf_load_stackoverflow)
FR2500434B1 (enrdf_load_stackoverflow)
FR2501936B1 (enrdf_load_stackoverflow)
FR2502223B1 (enrdf_load_stackoverflow)
FR2499231B1 (enrdf_load_stackoverflow)
FR2501020B1 (enrdf_load_stackoverflow)
GR76017B (enrdf_load_stackoverflow)
FR2499349B3 (enrdf_load_stackoverflow)
FR2500999B1 (enrdf_load_stackoverflow)
FR2500865B1 (enrdf_load_stackoverflow)
FR2501123B1 (enrdf_load_stackoverflow)
FR2499104B1 (enrdf_load_stackoverflow)
FR2499208B3 (enrdf_load_stackoverflow)
FR2499156B1 (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
EM Correction of a material error concerning inscription in the national patent register
ST Notification of lapse